用号称“工业母机”的高端机床卡中国脖子?日本的“自戕式豪赌”注定失败。 Actor Rachit Singh made his theatrical debut this year with Maddock Horror Comedy Universe's Thamma. The Aditya Sarpotdar directorial film starred Ayushmann Khurrana, Rashmika Mandanna and Nawazuddin Siddiqui in key roles. This was not the only milestone he achieved this year. Singh, who also worked as an acting coach for a decade, saw one of his students Shanaya Kapoor debut in the industry and another student, Aneet Padda, deliver one of the biggest blockbusters this year. And it was, indeed, a proud moment for the acting guru.
Talking of Aneet's success, the actor said, "It was one of those moments when you feel so happy for the other person that you just wish them all the love and luck. It was a proud moment because I was a small part of that journey. I have seen her grow and evolve and give the biggest blockbuster of the year. It is best when you are happy for somebody."
The actor came to Mumbai in 2013 but left because he couldn't figure out which career direction to choose. But he came back again in 2016 with a determination to make a mark.
"This time I decided I have to learn how to act. But I did not have any financial stability so to earn money, I started assisting Mr. Atul Mongia and worked as a workshop assistant. I learnt by watching people act in those workshops and I was also ended up learning how to give workshops. I then started conducting my own workshops under his company and eventually, I opened my own brand called Rachit Singh Workshop. It took me five more years to establish that and I was also giving auditions simultaneously. Then I got a show called Karma Calling, which was my first break and then Maddock happened."
View this post on Instagram
A post shared by Rachit Singh (@rachitsingh08)
In Thamma, Rachit played Veeran, a loyal devotee of the Betaal sect who worshipped Thama Yakshasan, portrayed by Siddiqui. His association with Maddock Films goes back to even before Thamma, and an interaction with Amar Kaushik led to him being cast in the film. "My first job with Maddock was as an acting coach and I was working in Munjya. I met Aditya and Amar and that's how the association began. Around Diwali last year, I met Amar sir and we got into a conversation about the projects I was working on. But after a few days, he called me to tell me about Thamma and said that he wanted me to play a role in it."
Singh's first day on set felt like a dream come true, with everything he had imagined about films and filmmaking coming alive right in front of him.
"My first day on set was quite exciting because I was waiting to do my first film. But we were shooting in the interiors of Delhi and it was chaotic. There were too many people in the narrow lanes when we were shooting for a chase scene and the crew was keeping the crowd away and helping us shoot. It was beautiful to see how much goes into making a film. That experience made me realise a lot about filmmaking, cinema and what goes behind the camera. But the first day on set it very special because you are seeing everything you have thought and imagined for so many years coming alive in front of you," the actor said.
Rachit also shared that it was a heartfelt moment for his when a lot of the aspiring actors he trained, reached out to him after his performance in Thamma. The actor will reportedly be seen in Baby Do Die Do.
Also Read: Thamma Director Reveals Shraddha Kapoor Was Considered to Play a Part in Munjya。

二 | 近日,日本新修订的《输出贸易管理令》正式生效。这意味着,一些精密机床对华出口从批量许可变为“一事一议”,审批周期最长可能被拉至半年,尤其是在航空航天、军工、半导体等重点行业,被驳回率可能将超过80%。日本指望打出“机床牌”卡住中国脖子,换取稀土供应等谈判筹码,同时也向美国对华遏制战略递上“投名状”。然而,这注定是一场“自损一千”的战略妄想。一方面,中国市场是日本机床企业最重要的盈利来源,占其海外出口总额约32%。据《日本经济新闻》报道,日本国内机床订单额自2023年开始已连续3年下滑。在这样的背景下,强行断供中国订单,对日本机床企业无异于“自残”。另一方面,中国高端机床早已不是白纸一张,而是正处在从“助跑”到“腾飞”的临界点。在中低端市场,国产替代早已铺开;在高端领域,一批企业也在加速突围。今年1月,德国机床制造商协会发布的数据显示,中国机床出口超过德国首次跃居全球首位。该协会称,中国占全球机床出口业务的份额为21.6%,而德国降到了16.7%。当然,相比国际尖端水平,中国高端机床的现实差距也必须正视。过去,国内企业习惯了“造不如买”,这不仅将国内市场让给了外方,也让国产设备缺少大规模试错验证、积累经验的机会。如今,当下游用户别无选择,国产设备将迎来一场证明自己的“大考”。

三 | 短期阵痛可能无法避免,但长期看,这必将倒逼国产供应链完成升级。历史反复证明,中国这么大市场,“卡脖子”卡不住中国。任何试图通过技术封锁遏制中国发展的企图,最终都是倒逼中国完成自主可控,最终只会失去中国市场。

四 | 病急乱投医,日方不反思自身的病灶,反而在错误道路上狂飙突进,其结果早已注定。